Avant Garde/Avenir award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders)
Department of Health and Human Services
Description
The National Institute on Drug Abuse (NIDA) plans to announce a funding opportunity for innovative research on HIV and substance use or substance use disorder (SUD). The Avant-Garde Award Program seeks to fund highly creative scientists proposing groundbreaking, high-risk, and potentially transformative research in this area. The program will also support early stage investigators. Although applications are not being accepted yet, this notice is to give potential applicants time to form coll…
The National Institue on Drug Abuse (NIDA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on pioneering research in HIV and Substance use/substance use disorder (SUD) research. The Avant-Garde Award Program is designed to support exceptionall…
Source
Grant ID
FOR-DA-27-003
Agency
Department of Health and Human Services
Subcategory/Subagency
National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Small businesses
- County governments
- State governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Private institutions of higher education
- For profit organizations other than small businesses
- Public housing authorities/Indian housing authorities
- Independent school districts
Links
Similar opportunities
- Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)
Department of Health and Human Services
- Notice of Funding Opportunity for Research at the Intersection of HIV and Substance Use
National Institutes of Health
- National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA)
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Research at the Intersection of HIV and Substance Use
National Institutes of Health
- Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
National Institutes of Health